Accumulating evidence has demonstrated that CD34+ cells transplantation is a promising therapeutic method against cerebral ischemic diseases, such as stroke, traumatic brain injury, and spinal cord injury [11, 13, 14]. The gene discussed is CD34; the disease is stroke disorder.